Elite Scientists Admit AI Now Does Most of Their Thinking

💡 DMK Insight

So, AI is taking over 90% of the intellectual workload in research, and here’s why that matters: this shift could reshape not just the tech landscape but also the financial markets. As AI tools become more integrated into scientific discovery, sectors like biotech and pharmaceuticals could see accelerated innovation cycles, potentially leading to rapid stock movements. Traders should keep an eye on companies heavily invested in AI technologies or those that could benefit from faster research and development timelines. But there’s a flip side—this reliance on AI could raise ethical concerns and regulatory scrutiny, which might create volatility in stocks tied to AI advancements. If researchers start to question the role of AI in their work, it could lead to a backlash against companies that heavily promote AI-driven solutions. Watch for any regulatory announcements or public sentiment shifts that could impact AI-related stocks. The next few weeks could be pivotal as these discussions unfold, so keep your charts ready for any sudden price movements in related sectors.